Last updated September 2023 - Microbiology and Molecular Genetics
(1) Heidari M, Golenser J, Greiner A. Meeting the Needs of a Potent Carrier for Malaria Treatment: Encapsulation of Artemisone in Poly(lactide-co-glycolide) Micro- and Nanoparticles. Part Part Syst Charact 2022;39(5).
(2) Zech J, Dzikowski R, Simantov K, Golenser J, Mäder K. Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria. Int J Parasitol Drugs Drug Resist 2021;16:148-154.
(3) Zech J, Salaymeh N, Hunt NH, Mäder K, Golenser J. Efficient treatment of experimental cerebral malaria by an artemisone-SMEDDS system: Impact of application route and dosing frequency. Antimicrob Agents Chemother 2021;65(4).
(4) Belay C, Steinman NY, Campos LM, Dzikowski R, Golenser J, Domb AJ. Asymmetric trisalkylamine cyclopropenium derivatives with antimicrobial activity. Bioorg Chem 2020;102.
(5) Golenser J, Salaymeh N, Higazi AA, Alyan M, Daif M, Dzikowski R, et al. Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation. Front Pharmacol 2020;11.
(6) Zech J, Gold D, Salaymeh N, Sasson NC, Rabinowitch I, Golenser J, et al. Oral administration of artemisone for the treatment of schistosomiasis: Formulation challenges and in vivo efficacy. Pharmaceutics 2020;12(6).
(7) Bagheri AR, Golenser J, Greiner A. Controlled and manageable release of antimalarial Artemisone by encapsulation in biodegradable carriers. Eur Polym J 2020;129.
(8) Steinman NY, Starr RL, Brucks SD, Belay C, Meir R, Golenser J, et al. Cyclopropenium-Based Biodegradable Polymers. Macromolecules 2019;52(9):3543-3550.
(9) Duan G, Bagheri AR, Jiang S, Golenser J, Agarwal S, Greiner A. Exploration of Macroporous Polymeric Sponges As Drug Carriers. Biomacromolecules 2017;18(10):3215-3221.
(10) Gold D, Alian M, Domb A, Karawani Y, Jbarien M, Chollet J, et al. Elimination of Schistosoma mansoni in infected mice by slow release of artemisone. Int J Parasitol Drugs Drug Resist 2017;7(2):241-247.
(11) Golenser J, Buchholz V, Bagheri A, Nasereddin A, Dzikowski R, Guo J, et al. Controlled release of artemisone for the treatment of experimental cerebral malaria. Parasites Vectors 2017;10(1).
(12) Mazuz ML, Shkap V, Wollkomirsky R, Leibovich B, Savitsky I, Fleiderovitz L, et al. Neospora caninum: Chronic and congenital infection in consecutive pregnancies of mice. Vet Parasitol 2016;219:66-70.
(13) Basu A, Veprinsky-Zuzulia I, Levinman M, Barkan Y, Golenser J, Domb AJ. PEG-Biscyanoacrylate Crosslinker for Octyl Cyanoacrylate Bioadhesive. Macromol Rapid Commun 2016;37(3):251-256.
(14) Portnoy E, Vakruk N, Bishara A, Shmuel M, Magdassi S, Golenser J, et al. Indocyanine green liposomes for diagnosis and therapeutic monitoring of cerebral malaria. Theranostics 2016;6(2):167-176.
(15) Portnoy E, Nizri E, Golenser J, Shmuel M, Magdassi S, Eyal S. Imaging the urinary pathways in mice by liposomal indocyanine green. Nanomed Nanotechnol Biol Med 2015;11(5):1057-1064.
(16) Mazuz ML, Fish L, Wolkomirsky R, Leibovich B, Reznikov D, Savitsky I, et al. The effect of a live Neospora caninum tachyzoite vaccine in naturally infected pregnant dairy cows. Prev Vet Med 2015;120(2):232-235.
(17) Mazuz LM, Wolkomirsky R, Sherman A, Savitzsky I, Waner T, Golenser J, et al. Concurrent neosporosis and hepatozoonosis in a litter of pups. Isr J Vet Med 2015;70(1):53-56.
(18) Guo J, Waknine-Grinberg JH, Mitchell AJ, Barenholz Y, Golenser J. Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β -methasone nanodrug. BioMed Res Int 2014;2014.
(19) Mazuz ML, Fish L, Reznikov D, Wolkomirsky R, Leibovitz B, Savitzky I, et al. Neosporosis in naturally infected pregnant dairy cattle. Vet Parasitol 2014;205(1-2):85-91.
(20) Khaw LT, Ball HJ, Mitchell AJ, Grau GE, Stocker R, Golenser J, et al. Brain endothelial cells increase the proliferation of Plasmodium falciparum through production of soluble factors. Exp Parasitol 2014;145(1):34-41.
(21) Guiguemde WA, Hunt NH, Guo J, Marciano A, Haynes RK, Clark J, et al. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: Antiplasmodial effects and immune responses. Antimicrob Agents Chemother 2014;58(8):4745-4754.
(22) Mazuz ML, Golenser J, Fish L, Haynes RK, Wollkomirsky R, Leibovich B, et al. Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites. Exp Parasitol 2013;135(4):690-694.
(23) Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, et al. Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria. PLoS ONE 2013;8(8).
(24) Khaw LT, Ball HJ, Golenser J, Combes V, Grau GE, Wheway J, et al. Endothelial Cells Potentiate Interferon-γ Production in a Novel Tripartite Culture Model of Human Cerebral Malaria. PLoS ONE 2013;8(7).
(25) Golenser J, Hunt N. Neglected aspects of drug discovery - microbiological aspects. Curr Clin Pharmacol 2013;8(1):73-80.
(26) Mazuz ML, Haynes R, Shkap V, Fish L, Wollkomirsky R, Leibovich B, et al. Neospora caninum: In vivo and in vitro treatment with artemisone. Vet Parasitol 2012;187(1-2):99-104.
(27) Guo J, Guiguemde AW, Bentura-Marciano A, Clark J, Haynes RK, Chan W-, et al. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Antimicrob Agents Chemother 2012;56(1):163-173.
(28) McQuillan JA, Mitchell AJ, Ho YF, Combes V, Ball HJ, Golenser J, et al. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria. Int J Parasitol 2011;41(2):155-163.
(29) Ohayon A, Golenser J, Sinay R, Tamir A, Altman A, Pollack Y, et al. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria. Infect Immun 2010;78(10):4195-4205.
(30) Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillan JA, Chan H-, Chan W-, et al. Artemisone effective against murine cerebral malaria. Malaria J 2010;9(1).
(31) Domb AJ, Yudovin-Farber I, Golenser J, Beyth N, Weiss EI. Quaternary ammonium polyethyleneimine: Antibacterial activity. J Nanomater 2010;2010.
(32) Hunt NH, Grau GE, Engwerda C, Barnum SR, van der Heyde H, Hansen DS, et al. Murine cerebral malaria: the whole story. Trends Parasitol 2010;26(6):272-274.
(33) Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J. Modulation of cerebral malaria by fasudil and other immune-modifying compounds. Exp Parasitol 2010;125(2):141-146.
(34) Waknine-Grinberg JH, Gold D, Ohayon A, Flescher E, Heyfets A, Doenhoff MJ, et al. Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malaria J 2010;9(1).
(35) Waknine-Grinberg JH, El-On J, Barak V, Barenholz Y, Golenser J. The immunomodulatory effect of Sambucol on leishmanial and malarial infections. Planta Med 2009;75(6):581-586.
(36) Brin YS, Nyska A, Domb AJ, Golenser J, Mizrahi B, Nyska M. Biocompatibility of a polymeric implant for the treatment of osteomyelitis. J Biomater Sci Polym Ed 2009;20(7-8):1081-1090.
(37) Yudovin-Farber I, Beyth N, Nyska A, Weiss EI, Golenser J, Domb AJ. Surface characterization and biocompatibility of restorative resin containing nanoparticles. Biomacromolecules 2008;9(11):3044-3050.
(38) Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, et al. Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 2008;131(2):121-127.
(39) Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Int J Pharm 2008;358(1-2):114-120.
(40) Zeiman E, Greenblatt CL, Elgavish S, Khozin-Goldberg I, Golenser J. Mode of action of fenarimol against Leishmania spp. J Parasitol 2008;94(1):280-286.
(41) Levy A, Pitcovski J, Frankenburg S, Elias O, Altuvia Y, Margalit H, et al. A melanoma multiepitope polypeptide induces specific CD8+ T-cell response. Cell Immunol 2007;250(1-2):24-30.
(42) Krasko MY, Golenser J, Nyska A, Nyska M, Brin YS, Domb AJ. Gentamicin extended release from an injectable polymeric implant. J Control Release 2007;117(1):90-96.
(43) Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE. Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 2006;36(14):1427-1441.
(44) Touitou E, Waknine JH, Godin B, Golenser J. Treatment of malaria in a mouse model by intranasal drug administration. Int J Parasitol 2006;36(14):1493-1498.
(45) Rosenberg E, Litus I, Schwarzfuchs N, Sinay R, Schlesinger P, Golenser J, et al. pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J Biol Chem 2006;281(37):27039-27045.
(46) Sokolsky-Papkov M, Domb AJ, Golenser J. Impact of aldehyde content on amphotericin B - Dextran imine conjugate toxicity. Biomacromolecules 2006;7(5):1529-1535.
(47) Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006;36(5):569-582.
(48) Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH. Conventional and experimental treatment of cerebral malaria. Int J Parasitol 2006;36(5):583-593.
(49) Golenser J, Domb A. New formulations and derivatives of Amphotericin B for treatment of leishmaniasis. Mini-Rev Med Chem 2006;6(2):153-162.
(50) Golenser J, Hunt NH, Sarel S. Probing for Antiparasitic Drugs. Mini-Rev Med Chem 2006;6(2):121-122.
(51) Golenser J, Domb A, Mordechal-Daniel T, Leshem B, Lutyt A, Kremsner P. Iron chelators: Correlation between effects on Plasmodium spp. and immune functions. J Parasitol 2006;92(1):170-177.
(52) Ehrenfreund-Kleinman T, Domb AJ, Jaffe CL, Nasereddin A, Leshem B, Golenser J. The effect of amphotericin B derivatives on Leishmania and immune functions. J Parasitol 2005;91(1):158-163.
(53) Ehrenfreund-Kleinman T, Golenser J, Domb AJ. Polysaccharide scaffolds for tissue engineering. Scaffolding in Tissue Engineering; 2005. p. 27-44.
(54) Bekerman T, Golenser J, Domb A. Cyclosporin Nanoparticulate Lipospheres for Oral Administration. J Pharm Sci 2004;93(5):1264-1270.
(55) Ehrenfreund-Kleinman T, Golenser J, Domb AJ. Conjugation of amino-containing drugs to polysaccharides by tosylation: Amphotericin B-arabinogalactan conjugates. Biomaterials 2004;25(15):3049-3057.
(56) Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci 2004;93(12):2927-2935.
(57) Ginsburg H, Golenser J. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep 2003;8(5):276-279.
(58) Golenser J, Domb A, Leshem B, Kremsner P, Luty A. Iron chelators as drugs against malaria pose a potential risk. Redox Rep 2003;8(5):268-271.
(59) Ehrenfreund-Kleinman T, Domb AJ, Golenser J. Polysaccharide Scaffolds Prepared by Crosslinking of Polysaccharides with Chitosan or Proteins for Cell Growth. J Bioact Compat Polym 2003;18(5):323-338.
(60) Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochem Pharmacol 2003;66(5):809-817.
(61) Ehrenfreund-Kleinman T, Gazit Z, Gazit D, Azzam T, Golenser J, Domb AJ. Synthesis and biodegradation of arabinogalactan sponges prepared by reductive amination. Biomaterials 2002;23(23):4621-4631.
(62) Hazra B, Golenser J, Nechemiya O, Bhattacharyya S, Azzam T, Domb A, et al. Inhibitory activity of diospyrin derivatives against Leishmania major parasites in vitro. Indian J Pharmacol 2002;34(6):422-427.
(63) Ehrenfreund-Kleinman T, Azzam T, Falk R, Polacheck I, Golenser J, Domb AJ. Synthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugates. Biomaterials 2002;23(5):1327-1335.
(64) Arabinogalactan based sponges for tissue engineering. American Chemical Society, Polymer Preprints, Division of Polymer Chemistry; 2002.
(65) Schwartz E, Paul F, Pener H, Almog S, Rotenberg M, Golenser J. Malaria antibodies and mefloquine levels among United Nations troops in Angola. J Travel Med 2001;8(3):113-116.
(66) Barkan D, Ginsburg H, Golenser J. Optimisation of flow cytometric measurement of parasitaemia in plasmodium-infected mice. Int J Parasitol 2000;30(5):649-653.
(67) Schwartz E, Samuni A, Friedman I, Hempelmann E, Golenser J. The role of superoxide dismutation in malaria parasites. Inflammation 1999;23(4):361-370.
(68) Ginsburg H, Golenser J. Redox metabolism in glucose-6-phosphate dehydrogenase deficient erythrocytes and its relation to antimalarial chemotherapy. Parassitologia 1999;41(1-3):309-311.
(69) Golenser J, Frankenburg S, Ehrenfreund T, Domb AJ. Efficacious treatment of experimental leishmaniasis with amphotericin B- arabinogalactan water-soluble derivatives. Antimicrob Agents Chemother 1999;43(9):2209-2214.
(70) Golenser J, Peled-Kamar M, Schwartz E, Friedman I, Groner Y, Pollack Y. Transgenic mice with elevated level of CuZnSOD are highly susceptible to malaria infection. Free Radic Biol Med 1998;24(9):1504-1510.
(71) Golenser J, Domb A, Teomim D, Tsafack A, Nisim O, Ponka P, et al. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release. J Pharmacol Exp Ther 1997;281(3):1127-1135.
(72) Schwartz E, Pener H, Issa SM, Golenser J. An overview of the malaria situation in Zanzibar. J Community Health 1997;22(1):33-44.
(73) Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M, Tsafack A. Iron Chelators: Mode of Action as Antimalarials. Acta Haematol 1996;95(1):70-77.
(74) Chevion M, Chuang L, Golenser J. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture. Antimicrob Agents Chemother 1995;39(8):1902-1905.
(75) Tsafack A, Golenser J, Libman J, Shanzer A, Cabantchik ZI. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol Pharmacol 1995;47(2):403-409.
(76) Golenser J, Tsafack A, Amichai Y, Libman J, Shanzer A, Cabantchik ZI. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrob Agents Chemother 1995;39(1):61-65.
(77) Schwartz E, Golenser J. Treatment of malaria. Harefuah 1993;124(9):572-577.
(78) Har-el R, Marva E, Chevion M, Golenser J. Is hemin responsible for the susceptibility of plasmodia to oxidant stress? Free Radic Res 1993;18(5):279-290.
(79) Golenser J, Kamyl M, Tsafack A, Marva E, Cohen A, Kitrossky N, et al. Correlation between destruction of malarial parasites by polymorphonuclear leucocytes and oxidative stress. Free Radic Res 1992;17(4):249-262.
(80) Marva E, Golenser J, Cohen A, Kitrossky N, Har-El R, Chevion M. The effects of ascorbate-induced free radicals on Plasmodium falciparum. Trop Med Parasitol 1992;43(1):17-23.
(81) Freese JA, Markus MB, Golenser J. In vitro sensitivity of southern African reference isolates of Plasmodium falciparum to chloroquine and pyrimethamine. BULL WHO 1991;69(6):707-712.
(82) Golenser J, Marva E, Har-el R, Chevion M. Induction of oxidant stress by iron available in advanced forms of plasmodium falciparum. Free Radic Res 1991;13(1):639-643.
(83) Pollack Y, Kogan N, Golenser J. Plasmodium falciparum: Evidence for a DNA methylation pattern. Exp Parasitol 1991;72(4):339-344.
(84) Marva E, Chevion M, Golenser J. The effect of free radicals induced by paraquat and copper on the in vitro development of plasmodium falciparum. Free Radic Res 1991;12(1):137-146.
(85) Golenser J, Marva E, Chevion M. The survival of Plasmodium Under oxidant stress. Parasitol Today 1991;7(6):142-146.
(86) Messika E, Golenser J, Abu-Elheiga L, Robert-Gero M, Lederer E, Bachrach U. Effect of sinefungin on macromolecular biosynthesis and cell cycle of Plasmodium falciparum. Trop Med Parasitol 1990;41(3):273-278.
(87) Pollack Y, Segal R, Golenser J. The effect of ascaridole on the in vitro development of Plasmodium falciparum. Parasitol Res 1990;76(7):570-572.
(88) Freese JA, Markus MB, Golenser J. Typing of southern African isolates of Plasmodium falciparum using monoclonal antibodies. Am J Trop Med Hyg 1990;43(1):19-24.
(89) Marva E, Cohen A, Saltman P, Chevion M, Golenser J. Deleterious synergistic effects of ascorbate and copper on the development of Plasmodium falciparum: An in vitro study in normal and in G6PD-deficient erythrocytes. Int J Parasitol 1989;19(7):779-785.
(90) Golenser J, Chevion M. Oxidant stress and malaria: host-parasite interrelationships in normal and abnormal erythrocytes. Semin Hematol 1989;26(4):313-325.
(91) Golenser J, Miller J, Spira DT, Kosower NS, Vande Waa JA, Jensen JB. Inhibition of the intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor. Trop Med Parasitol 1988;39(4):273-276.
(92) Bachrach U, Abu-Elheiga L, Assaraf YG, Golenser J, Spira DT. Polyamines in the cell cycle of the malarial parasite Plasmodium falciparum. Adv Exp Med Biol 1988;250:643-650.
(93) Assaraf YG, Golenser J, Spira DT, Messer G, Bachrach U. Cytostatic effect of DL-α-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine. Parasitol Res 1987;73(4):313-318.
(94) Avidor B, Golenser J, Schutte CHJ, Cox GA, Isaacson M, Sulitzeanu D. A radioimmunoassay for the diagnosis of malaria. Am J Trop Med Hyg 1987;37(2):225-229.
(95) Morgan DML, Bachrach U, Assaraf YG, Harari E, Golenser J. The effect of purified aminoaldehydes produced by polyamine oxidation on the development in vitro of Plasmodium falciparum in normal and glucose-6-phosphate-dehydrogenase-deficient erythrocytes. Biochem J 1986;236(1):97-101.
(96) Assaraf YG, Golenser J, Spira DT, Bachrach U. Plasmodium falciparum: Synchronization of cultures with dl-α-difluoromethylornithine, an inhibitor of polyamine biosynthesis. Exp Parasitol 1986;61(2):229-235.
(97) Avidor B, Golenser J, Sulitzeanu D. Detection of Plasmodium falciparum using a radioimmunoassay based on a crossreacting, monoclonal anti-P. berghei antibody-P. berghei antigen system. J Immunol Methods 1985;82(1):121-129.
(98) Pollack Y, Metzger S, Shemer R, Landau D, Spira DT, Golenser J. Detection of Plasmodium falciparum in blood using DNA hybridization. Am J Trop Med Hyg 1985;34(4):663-667.
(99) Pollack Y, Shemer R, Metzger S, Spira DT, Golenser J. Plasmodium falciparum: Expression of the adenine phosphoribosyltransferase gene in mouse L cells. Exp Parasitol 1985;60(3):270-275.
(100) Golenser J, Marva E, Spira DT, Gabrielsen AA, Jensen JB. Mitogenic and antigenic activity of Plasmodium falciparum in primate and rodent lymphocytes. Int J Parasitol 1985;15(4):435-440.
(101) Pass A, Avidor B, Golenser J, Laskov R, Sulitzeanu D. Use of a monoclonal, anti Plasmodium berghei antibody, cross reacting with P. falciparum, for the detection of P. falciparum in in vitro infected blood. Immunol Lett 1985;10(1):31-34.
(102) Miller J, Golenser J, Spira DT, Kosower NS. Plasmodium falciparum: Thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes. Exp Parasitol 1984;57(3):239-247.
(103) Assaraf YG, Golenser J, Spira DT, Bachrach U. Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum. Biochem J 1984;222(3):815-819.
(104) Avraham H, Golenser J, Bunnag D, Suntharasamai P, Tharavanij S, Harinasuta KT, et al. Preliminary field trial of a radioimmunoassay for the diagnosis of malaria. Am J Trop Med Hyg 1983;32(1):11-18.
(105) Golenser J, Miller J, Spira DT, Navok T, Chevion M. Inhibitory effect of a fava bean component on the in vitro development of Plasmodium falciparum in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes. Blood 1983;61(3):507-510.
(106) Golenser J, Miller J, Avraham H, Spira DT. The inhibitory effect of human immune sera upon the in vitro development of Plasmodium falciparum. Trop Geogr Med 1983;35(1):15-20.
(107) Avraham H, Golenser J, Gazitt Y, Spira DT, Sulitzeanu D. A highly sensitive solid-phase radioimmunoassay for the assay of Plasmodium falciparum antigens and antibodies. J Immunol Methods 1982;53(1):61-68.
(108) Pollack Y, Katzen AL, Spira DT, Golenser J. The genome of plasmodium falciparum. I: DNA base composition. Nucleic Acids Res 1982;10(2):539-546.
(109) Golenser J, Shmuel Z, Spira DT. Aspects of immunosuppression during Plasmodium berghei infection in rats. Trop Geogr Med 1981;33(4):347-354.
(110) Golenser J, Casuto D, Pollack Y. Plasmodium falciparum: In vitro induction of resistance to aminopterin. Exp Parasitol 1981;52(3):371-377.
(111) Hava Avraham V, Golenser J, Spira DT, Sulitzeanu D. Plasmodium falciparum, assay of antigens and antibodies by means of a solid phase radioimmunoassay with radioiodinated staphylococcal protein a. Trans R Soc Trop Med Hyg 1981;75(3):421-425.
(112) Weissberger H, Golenser J, Spira DT. Plasmodium berghei: Specific stimulation of rat lymphocytes by soluble antigens released in vitro from infected erythrocytes. Exp Parasitol 1980;50(1):136-143.
(113) Verhave JP, Meuwissen JHET, Golenser J. The dual role of macrophages in the sporozoite-induced malaria infection. A hypothesis. Int J Nucl Med Biol 1980;7(2):149-156.
(114) Weissberger H, Golenser J, Spira DT. Soluble antigens released in vitro from erythrocytes infected with Plasmodium berghei. BULL WHO 1979;57(Suppl. 1):83.
(115) Golenser J, Verhave JP, de Valk J, Heeren J, Meuwissen JH. Studies on the role of antibodies against sporozoites in Plasmodium berghei malaria. Isr J Med Sci 1978;14(5):606-610.
(116) Meuwissen Th. JHE, Golenser J, Verhave JP. Development of effective antisporozoite immunity by natural bites of Plasmodium berghei infected mosquitoes in rats under prophylactic treatment with various drug regimens. Isr J Med Sci 1978;14(5):601-605.
(117) Verhave JP, Meuwissen Th. JHE, Golenser J. Cell mediated reactions and protection after immunization with sporozoites. Isr J Med Sci 1978;14(5):611-616.
(118) Golenser J, Heeren J, Verhave JP, Kaay HJ, Meuwissen JH. Crossreactivity with sporozoites, exoerythrocytic forms and blood schizonts of Plasmodium berghei in indirect fluorescent antibody tests with sera of rats immunized with sporozoites or infected blood. Clin Exp Immunol 1977;29(1):43-51.
(119) Zuckerman A, Spira DT, Golenser J. Characterization of spleen cells from rats immune to plasmodium berghei and injected with cyclophosphamide (CP). J Protozool 1977;24(2 , sup).
(120) Frankenburg S, Greenblatt CL, Golenser J, Spira DT. Plasmodium berghei: Relationship between mitosis and erythropoiesis in spleen cells of infected rats. Exp Parasitol 1977;43(2):362-369.
(121) Zuckerman A, Spira DT, Golenser J. Protective potential of a spleen cell population from Lewis rats recovered from Plasmodium berghei and pretreated with cyclophosphamide (CY) before adoptive transfer. J Protozool 1977;24(2 , sup).
(122) Spira DT, Golenser J, Gery I. The reactivity of spleen cells from malarious rats to non specific mitogens. Clin Exp Immunol 1976;24(1):139-145.
(123) Golenser J, Spira DT, Verhave JP, Meuwissen JHET. Specific lymphocyte transformation in murine malaria. Z F Parasitenkunde 1976;50(1):95-98.
(124) Golenser J, Spira DT, Zuckerman A. Dynamics of thymidine incorporation by spleen cells from rats infected with Plasmodium berghei. Clin Exp Immunol 1975;22(2):364-371.
(125) Golenser J, Spira DT, Zuckerman A. Neutralizing antibody in rodent malaria. Trans R Soc Trop Med Hyg 1975;69(2):251-258.
(126) Russell A, Ornoy A, Ritchie J, Golenser J, Fein A, Nebel L. Transplacental and neonatal effects of hypercortisonism in the rat on thymo-lymphatic system differentiation and serum immunoglobulin levels. Adv Exp Med Biol 1972;27:257-271.
(127) Spira DT, Golenser J, Zuckerman A, Neiss R. Multiple modes of action of cyclophosphamide on plasmodial infections in rats. Trans R Soc Trop Med Hyg 1972;66(6):921-930.